Dynamicure Biotechnology LLC is a startup IO immunotherapy firm located in Waltham MA, established to pioneer the next age of immunotherapies.
Dynamicure operates a high-throughput Ab discovery program and a state-of-the-art sdAb phage-display antibody discovery platform to generate high-quality, well-characterized, therapeutic antibodies against every extracellular protein in the mouse and human genomes.
Dynamicure is committed to enabling the world with these transformative reagents to accelerate biological development and the evolution of new therapeutics.